Chris Tannous, President of the Board of the Komen Orange County Affiliate, recently wrote an excellent article about the exciting new scientific developments that are moving us toward improved mortality rates for breast cancer in the next decade. Today, advocates play a role in the development of research projects and clinical trial protocols. Chris writes, “Advocates have put a face on the disease and remind scientists that their research must benefit those in greatest need of their expertise and experience.” And as Komen for the Cure founder Nancy Brinker pointed out in her visit to Orange County in June, no major advancement in breast health medicine or research has been made without the funding of Komen for the Cure at some point along the way. It really helps to put into perspective the vital role that Komen plays in the fight to end breast cancer forever. To read Chris’s full article, click on the picture below.
Posted on July 16, 2009 by Komen OC